Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: A phase II, multi-institutional clinical trial

Journal of Thoracic and Cardiovascular Surgery

Volumn 147, Issue 1, 2014, Pages

  Korst, Robert J ^a,b,c   Bezjak, Andrea ^c,d   Blackmon, Shanda ^e   Choi, Noah ^f   Fidias, Panos ^f   Liu, Geoffrey ^c,d   Marx, Alexander ^c,g   Wright, Cameron ^c,f   Mock, Susan ^a   Rutledge, John R ^a   Keshavjee, Shaf ^c,h  

^a Valley Hospital   (United States)

^b VALLEY HOSPITAL   (United States)

^c International Thymic Malignancy Interest Group   (United States)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e HOUSTON METHODIST HOSPITAL   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEHYDRATION; DRESSLER SYNDROME; DRUG HYPERSENSITIVITY; ESOPHAGITIS; FEBRILE NEUTROPENIA; FEMALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEMATOTHORAX; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG INFILTRATE; MALE; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; MYASTHENIA GRAVIS; NAUSEA AND VOMITING; NEUTROPENIA; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PLEURA EFFUSION; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; STERNOTOMY; THORACOTOMY; THROMBOCYTOPENIA; THYMOMA; TINNITUS; TUMOR RECURRENCE;

EID: 84890564159     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.08.061     Document Type: Article

References (18)

1. F.C. Detterbeck, and A.M. Parsons Thymic tumors Ann Thorac Surg 77 2004 1860 1869
2. E.S. Kim, J.B. Putnam, R. Komaki, G.L. Walsh, J.Y. Ro, and H.J. Shin Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report Lung Cancer 44 2004 369 379
3. H. Kunitoh, T. Tamura, T. Shibata, K. Takeda, N. Katakami, and K. Nakagawa A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606) Br J Cancer 103 2010 6 11
4. M. Lucchi, M.C. Ambrogi, L. Duranti, F. Basalo, G. Fontanini, and C.A. Angeletti Advanced stage thymomas and thymic carcinomas: results of multimodality treatments Ann Thorac Surg 79 2005 1840 1844
5. F. Venuta, E.A. Rendina, F. Longo, T. De Giacomo, M. Anile, and E. Mercadante Long-term outcome after multimodality treatment for stage III thymic tumors Ann Thorac Surg 76 2003 1866 1872
6. F. Rea, F. Sartori, M. Loy, F. Calabro, A. Fornasiero, and O. Daniele Chemotherapy and operation for invasive thymoma J Thorac Cardiovasc Surg 106 1993 543 549
7. P. Macchiarini, A. Chella, F. Ducci, B. Rossi, C. Testi, and G. Bevilacqua Neoadjuvant chemotherapy, surgery, and postoperative radiation for invasive thymoma Cancer 68 1991 706 713
8. T. Onuki, S. Ishikawa, T. Yamamoto, H. Ito, M. Sakai, and M. Onizuka Pathologic radioresponse of preoperatively irradiated invasive thymomas J Thorac Oncol 3 2008 270 276
9. J. Rosai, and L. Sobin Histologic typing of tumors of the thymus World Health Organization International Histological Classification of Tumors 2nd ed. 1999 Springer New York 9 14
10. A. Masaoka, Y. Monden, K. Nakahara, and T. Tanioka Follow-up study of thymomas with special reference to their clinical stages Cancer 48 1981 2485 2492
11. E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, and R. Ford New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
12. N. Tomiyama, N.L. Muller, S.J. Ellis, J.R. Cleverley, M. Okumura, and S. Miyoshi Invasive and noninvasive thymoma: distinctive CT features J Comput Assist Tomogr 25 2001 388 393
13. E.M. Marom, M.L. Rosado-de-Christenson, J.F. Bruzzi, M. Hara, J.R. Sonnett, and L. Ketai Standard report terms for chest computed tomography reports of anterior mediastinal masses suspicious for thymoma J Thorac Oncol 6 2011 S1717 S1723
14. M.C. Adams, T.G. Turkington, J.M. Wilson, and T.Z. Wong A systematic review of the factors affecting accuracy of SUV measurements AJR Am J Roentgenol 195 2010 310 320
15. K. Fukumoto, T. Taniguchi, Y. Ishikawa, K. Kawaguchi, T. Fukui, and K. Matsuo The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumors Eur J Cardiothorac Surg 42 2012 e152 e156
16. A. Terzi, L. Bertolaccini, G. Rizzardi, L. Luzzi, A. Bianchi, and A. Campione Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms Lung Cancer 74 2011 239 243
17. M.F. Benveniste, C.A. Moran, O. Mawlawi, P.S. Fox, S.G. Swisher, and R.F. Munden FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies J Thorac Oncol 8 2013 502 510
18. C.D. Wright, N.C. Choi, J.C. Wain, D.J. Mathisen, T.J. Lynch, and P. Fidias Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors Ann Thorac Surg 85 2008 385 389